Peter A.M. Anderson

Suggest Changes
Learn More
PURPOSE Temsirolimus was combined with cixutumumab, a fully human IgG1 monoclonal antibody directed at the insulin growth factor-1 receptor (IGF-1R). EXPERIMENTAL DESIGN Patients received(More)